Company Profile
MedMira Inc., a biotechnology company researches, develops, manufactures, and sells rapid diagnostics and technology platforms globally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma.
Its portfolio also includes Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood, Multiplo, a line of multiplex tests for HIV-1/2, Hepatitis B and C, and syphilis, and Miriad triple product for preliminary screening of HIV and hepatitis
The Miriad RVF toolkit, which facilitates the development and commercialization of rapid diagnostics; and Reveal G4 HIV tests. Founded in 1993, the company is headquartered in Halifax, Canada. MedMira Inc. is a subsidiary of MedMira Holding AG.